ランジオロール (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "ランジオロール" in Japanese language version.

refsWebsite

Global rank Japanese rank

19nih.gov

4^th place

24^th place

14doi.org

2^nd place

6^th place

1pmda.go.jp

6,690^th place

394^th place

1kegg.jp

low place

2,161^st place

1cts-mrp.eu

low place

1worldcat.org

5^th place

19^th place

cts-mrp.eu

mri.cts-mrp.eu

“Rapibloc Summary of Product Characteristics”. Template:Cite webの呼び出しエラー：引数 accessdate は必須です。^{[リンク切れ]}

doi.org

“Landiolol has a less potent negative inotropic effect than esmolol in isolated rabbit hearts”. Journal of Anesthesia 22 (4): 361–6. (2008). doi:10.1007/s00540-008-0640-4. PMID 19011773.
“Practical applicability of landiolol, an ultra-short-acting β1-selective blocker, for rapid atrial and ventricular tachyarrhythmias with left ventricular dysfunction”. Journal of Arrhythmia 32 (2): 82–8. (April 2016). doi:10.1016/j.joa.2015.09.002. PMC 4823575. PMID 27092187.
“Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias”. Clinical Pharmacology and Therapeutics 68 (2): 143–50. (August 2000). doi:10.1067/mcp.2000.108733. PMID 10976545.
“Development of a highly cardioselective ultra short-acting beta-blocker, ONO-1101”. Chemical & Pharmaceutical Bulletin 40 (6): 1462–9. (June 1992). doi:10.1248/cpb.40.1462. PMID 1356643.
“The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors”. British Journal of Pharmacology 144 (3): 317–22. (February 2005). doi:10.1038/sj.bjp.0706048. PMC 1576008. PMID 15655528.
“Landiolol, an ultra-short-acting β1-blocker, is useful for managing supraventricular tachyarrhythmias in sepsis”. World Journal of Critical Care Medicine 4 (3): 251–7. (August 2015). doi:10.5492/wjccm.v4.i3.251. PMC 4524822. PMID 26261777.
European Heart Journal, ehaa612, https://doi.org/10.1093/eurheartj/ehaa612 Published: 29 August 2020
“Randomized clinical trial of landiolol hydrochloride for the prevention of atrial fibrillation and postoperative complications after oesophagectomy for cancer”. The British Journal of Surgery 104 (8): 1003–1009. (July 2017). doi:10.1002/bjs.10548. PMID 28444964.
“Landiolol in the treatment of the intraoperative supraventricular tachycardia: a multicenter, randomized, double-blind, placebo-controlled study”. Journal of Clinical Anesthesia 27 (2): 120–8. (March 2015). doi:10.1016/j.jclinane.2014.07.003. PMID 25434501.
“Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial”. The Journal of Thoracic and Cardiovascular Surgery 141 (6): 1478–87. (June 2011). doi:10.1016/j.jtcvs.2010.10.045. PMID 21269646.
“Landiolol, an ultra-short-acting β₁-blocker, more effectively terminates atrial fibrillation than diltiazem after open heart surgery: prospective, multicenter, randomized, open-label study (JL-KNIGHT study)”. Circulation Journal 76 (5): 1097–101. (2012). doi:10.1253/circj.CJ-11-1332. PMID 22361918.
“Efficacy and Safety of Landiolol Compared to Amiodarone for the Management of Postoperative Atrial Fibrillation in Intensive Care Patients”. Journal of Cardiothoracic and Vascular Anesthesia 30 (2): 418–22. (April 2016). doi:10.1053/j.jvca.2015.09.007. PMID 26703973.
“Beneficial effect of early infusion of landiolol, a very short-acting beta-1 adrenergic receptor blocker, on reperfusion status in acute myocardial infarction”. International Journal of Cardiology 221: 321–6. (October 2016). doi:10.1016/j.ijcard.2016.07.076. PMID 274046996
“Successful Treatment of Refractory Electrical Storm With Landiolol After More Than 100 Electrical Defibrillations”. International Heart Journal 56 (5): 555–7. (2015). doi:10.1536/ihj.15-102. PMID 26346519.

kegg.jp

“医療用医薬品 : コアベータ (コアベータ静注用12.5mg)”. www.kegg.jp. 2022年10月31日閲覧。

nih.gov

pubmed.ncbi.nlm.nih.gov

“Landiolol has a less potent negative inotropic effect than esmolol in isolated rabbit hearts”. Journal of Anesthesia 22 (4): 361–6. (2008). doi:10.1007/s00540-008-0640-4. PMID 19011773.
“Practical applicability of landiolol, an ultra-short-acting β1-selective blocker, for rapid atrial and ventricular tachyarrhythmias with left ventricular dysfunction”. Journal of Arrhythmia 32 (2): 82–8. (April 2016). doi:10.1016/j.joa.2015.09.002. PMC 4823575. PMID 27092187.
“Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias”. Clinical Pharmacology and Therapeutics 68 (2): 143–50. (August 2000). doi:10.1067/mcp.2000.108733. PMID 10976545.
“Development of a highly cardioselective ultra short-acting beta-blocker, ONO-1101”. Chemical & Pharmaceutical Bulletin 40 (6): 1462–9. (June 1992). doi:10.1248/cpb.40.1462. PMID 1356643.
“The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors”. British Journal of Pharmacology 144 (3): 317–22. (February 2005). doi:10.1038/sj.bjp.0706048. PMC 1576008. PMID 15655528.
“Landiolol, an ultra-short-acting β1-blocker, is useful for managing supraventricular tachyarrhythmias in sepsis”. World Journal of Critical Care Medicine 4 (3): 251–7. (August 2015). doi:10.5492/wjccm.v4.i3.251. PMC 4524822. PMID 26261777.
“Metoprolol Therapy and CYP2D6 Genotype”. Medical Genetics Summaries. National Center for Biotechnology Information (NCBI). (2017). PMID 28520381. Bookshelf ID: NBK4253893
Quon, C. Y.; Stampfli, H. F. (1985-07). “Biochemical properties of blood esmolol esterase”. Drug Metabolism and Disposition: The Biological Fate of Chemicals 13 (4): 420–424. ISSN 0090-9556. PMID 2863104.
“Randomized clinical trial of landiolol hydrochloride for the prevention of atrial fibrillation and postoperative complications after oesophagectomy for cancer”. The British Journal of Surgery 104 (8): 1003–1009. (July 2017). doi:10.1002/bjs.10548. PMID 28444964.
“Landiolol in the treatment of the intraoperative supraventricular tachycardia: a multicenter, randomized, double-blind, placebo-controlled study”. Journal of Clinical Anesthesia 27 (2): 120–8. (March 2015). doi:10.1016/j.jclinane.2014.07.003. PMID 25434501.
“Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial”. The Journal of Thoracic and Cardiovascular Surgery 141 (6): 1478–87. (June 2011). doi:10.1016/j.jtcvs.2010.10.045. PMID 21269646.
“Landiolol, an ultra-short-acting β₁-blocker, more effectively terminates atrial fibrillation than diltiazem after open heart surgery: prospective, multicenter, randomized, open-label study (JL-KNIGHT study)”. Circulation Journal 76 (5): 1097–101. (2012). doi:10.1253/circj.CJ-11-1332. PMID 22361918.
“Efficacy and Safety of Landiolol Compared to Amiodarone for the Management of Postoperative Atrial Fibrillation in Intensive Care Patients”. Journal of Cardiothoracic and Vascular Anesthesia 30 (2): 418–22. (April 2016). doi:10.1053/j.jvca.2015.09.007. PMID 26703973.
“Beneficial effect of early infusion of landiolol, a very short-acting beta-1 adrenergic receptor blocker, on reperfusion status in acute myocardial infarction”. International Journal of Cardiology 221: 321–6. (October 2016). doi:10.1016/j.ijcard.2016.07.076. PMID 274046996
“Successful Treatment of Refractory Electrical Storm With Landiolol After More Than 100 Electrical Defibrillations”. International Heart Journal 56 (5): 555–7. (2015). doi:10.1536/ihj.15-102. PMID 26346519.

ncbi.nlm.nih.gov

pmda.go.jp

info.pmda.go.jp

“オノアクト点滴静注用50mg／オノアクト点滴静注用150mg”. www.info.pmda.go.jp. 2022年10月31日閲覧。

worldcat.org

search.worldcat.org

Quon, C. Y.; Stampfli, H. F. (1985-07). “Biochemical properties of blood esmolol esterase”. Drug Metabolism and Disposition: The Biological Fate of Chemicals 13 (4): 420–424. ISSN 0090-9556. PMID 2863104.